
|Articles|August 1, 2003 (Updated: November 15, 2020)
- Pharmaceutical Executive-08-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 22 years ago
The $46 Million Manover 22 years ago
More Than Just a Pretty Faceover 22 years ago
Managing the Innovatorover 22 years ago
Protecting IP Throughout the Product LifecycleNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5




